Health Canada
- Status: approved
🇨🇦 placebo sitagliptin in Canada
placebo sitagliptin (placebo sitagliptin) regulatory status in Canada.
Marketing authorisation
placebo sitagliptin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Diabetes approved in Canada
Frequently asked questions
Is placebo sitagliptin approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for placebo sitagliptin in Canada?
GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.